DearGen | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

48 results for “DearGen”

Trials

View all 22 →

Improved Skin Whitening Outcomes Associated With Nicotinamide Fortified Consumption in 30 to 50- Year-old Women

70 participants · First posted Jan 25, 2023

Suturable DuraGen™ PMCF Study

260 participants · First posted Jun 11, 2021

Duragen Versus Duraguard in Chiari Surgery

34 participants · First posted Aug 26, 2008

Drugs

View all 10 →

Tri-Desogen

Keragen Implant

SGN-CEACAM5C(Seagen)

Organizations

Seagen Inc.

United States

EirGen Pharma Ltd.

Ireland

University of Bergen

Norway

News

View all 11 →

AI Revolution in Pharma: Transforming Drug Development to Patient Care

Former Seagen CEO Leads Ottimo Pharma's Novel Cancer Immunotherapy Development

Seagen Secures $2.6B Deal with RemeGen for Novel HER2-Targeting Cancer Drug

Page 1 of 5